Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7517
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Buprenorphine and naloxone access in pharmacies within high overdose areas of Los Angeles during the COVID-19 pandemic ; volume:19 ; number:1 ; day:29 ; month:6 ; year:2022 ; pages:1-6 ; date:12.2022
Harm reduction journal ; 19, Heft 1 (29.6.2022), 1-6, 12.2022
- Creator
-
Dadiomov, David
Bolshakova, Maria
Mikhaeilyan, Melania
Trotzky-Sirr, Rebecca
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12954-022-00651-3
- URN
-
urn:nbn:de:101:1-2022082020480844025761
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dadiomov, David
- Bolshakova, Maria
- Mikhaeilyan, Melania
- Trotzky-Sirr, Rebecca
- SpringerLink (Online service)
Other Objects (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state
Effectiveness of bystander naloxone administration and overdose education programs: a meta-analysis
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Naloxone availability in independent community pharmacies in Georgia, 2019
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Naloxone should remain the appropriate antidote to treat opioid overdose
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Preventing opioid overdose with peer-administered naloxone: findings from a rural state